Patheon Italia S.p.A. (manufacturing, primary packaging, quality control testing (sterility))

The drug is prescribed to adult patients with HER2-positive metastatic breast cancer or early breast cancer. It is also used for the treatment of HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma in combination with other drugs.

Dosage form: powder for concentrate for infusion solution

ATC: L01FD01